A detailed history of Seelaus Asset Management LLC transactions in Geron Corp stock. As of the latest transaction made, Seelaus Asset Management LLC holds 12,500 shares of GERN stock, worth $14,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,500
Previous 12,500 -0.0%
Holding current value
$14,000
Previous $17,000 -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 05, 2025

BUY
$1.18 - $1.62 $14,750 - $20,250
12,500 New
12,500 $17,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $423M
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Seelaus Asset Management LLC Portfolio

Follow Seelaus Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seelaus Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seelaus Asset Management LLC with notifications on news.